Long-Acting Injectable Buprenorphine Treatments for Opioid Use Disorder

This training fulfills the DEA’s 8-hour training requirement for prescribers. Free continuing education credits.

Sponsor: Grayken Center for Addiction Training and Technical Assistance

This training is designed to provide healthcare teams with information on all the available FDA-approved monthly/weekly injectable buprenorphine formulations used to treat opioid use disorder, as well as how to incorporate them into clinical practice

For more information and to register click here

Event Details

Date:
May 10, 2024
Time:
12:00 pm - 1:00 pm
Cost:
free